NCT02826837 2021-10-06
LEAC-102 for Advanced Colorectal Cancer
Taiwan Leader Biotech Corp.
Phase 1/2 Unknown
Clinical Trials
11 trialsNCT04872634 2021-07-21
SNK_ASTER
NKMAX Co., Ltd.
Phase 1/2 Unknown
NCT02054442 2021-03-12
COMMENCE
Radboud University Medical Center
Phase 1/2 Unknown
NCT02507154 2018-08-21
NKEXPHNC
National University Hospital, Singapore
Phase 1/2 Unknown
NCT03051906 2017-11-22
DUCRO-HN
Azienda Ospedaliero-Universitaria Careggi
Phase 1/2 Unknown
NCT00425425 2014-05-01
Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer
Technical University of Munich
Phase 1/2 Unknown
NCT01192087 2013-04-24
ACCEPT
Heidelberg University
Phase 1/2 Unknown
NCT01760811 2013-01-04
CETUXIMAB Given for 3 Weeks as Neoadjuvant Treatment in Locally Advanced Tongue Cancer ; A NEW PARADIGM OF TREATMENT
Rabin Medical Center
Phase 1/2 Unknown
NCT01166035 2010-07-20
TEXO
Medical University Innsbruck
Phase 1/2 Unknown
NCT00353717 2009-01-13
Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma
Hadassah Medical Organization
Phase 1/2 Unknown
NCT00311857 2006-09-08
Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)
Heidelberg University
Phase 1/2 Unknown